The estimated Net Worth of Cynthia M Patton is at least $11.2 Milion dollars as of 30 August 2019. Ms. Patton owns over 13,426 units of AMGEN stock worth over $7,291,568 and over the last 12 years she sold AMGN stock worth over $3,956,186. In addition, she makes $0 as Senior Vice President i Chief Compliance Officer at AMGEN.
Cynthia has made over 6 trades of the AMGEN stock since 2013, according to the Form 4 filled with the SEC. Most recently she sold 13,426 units of AMGN stock worth $2,793,548 on 30 August 2019.
The largest trade she's ever made was selling 13,426 units of AMGEN stock on 30 August 2019 worth over $2,793,548. On average, Cynthia trades about 534 units every 43 days since 2012. As of 30 August 2019 she still owns at least 22,097 units of AMGEN stock.
You can see the complete history of Ms. Patton stock trades at the bottom of the page.
Cynthia M. Patton serves as Senior Vice President, Chief Compliance Officer of the Company. Ms. Patton joined the Company in 2005. From 2005 to 2010, Ms. Patton was Associate General Counsel. From 2010 to 2012, Ms. Patton was Vice President, Law. Prior to joining the Company, Ms. Patton served as Senior Vice President, General Counsel and Secretary of SCAN Health Plan from 1999 to 2005.
Cynthia Patton is 58, she's been the Senior Vice President i Chief Compliance Officer of AMGEN since 2012. There are 14 older and 10 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.
Cynthia's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320-1799.
Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer oraz Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: